Dr. Reddy’s Laboratories expands wellness portfolio with MenoLabs acquisition
In a significant move within the healthcare industry, Dr. Reddy's Laboratories Ltd. has announced the acquisition of the MenoLabs business, a prominent player in women's ... Read More
Dr. Reddy’s Labs, Slayback sign licensing deal for Brimonidine Tartrate
Dr. Reddy’s Laboratories said that it has signed a licensing deal with New Jersey-based Slayback Pharma for acquiring rights in the latter’s Brimonidine Tartrate Ophthalmic ... Read More
Dr. Reddy’s Laboratories launches sorafenib generic in US
Dr. Reddy’s Laboratories said that it has launched Dr. Reddy’s Sorafenib Tablets, USP, 200 mg in the US market following the approval of the US ... Read More
Dr. Reddy’s, Senores launch Ketorolac Tromethamine Tablets in US
Dr. Reddy’s Laboratories and its partner Senores Pharmaceuticals have launched Ketorolac Tromethamine Tablets USP, 10 mg, in the US market. The launched product is a ... Read More
Dr. Reddy’s Laboratories relaunches OTC Naproxen Sodium Tablets in US
Dr. Reddy’s Laboratories said that it has relaunched over-the-counter (OTC) Naproxen Sodium Tablets USP, 220 mg, the store-brand equivalent of Bayer HealthCare’s Aleve, in the ... Read More
Dr. Reddy’s Laboratories launches Ertapenem for Injection in US
Dr. Reddy’s Laboratories has launched Ertapenem for Injection, 1 g/vial, a generic version of INVANZ (ertapenem for injection) for injection, 1 g/vial, which has approval ... Read More
Dr. Reddy’s Laboratories launches Sapropterin dihydrochloride powder in US
Dr. Reddy's Laboratories has launched Sapropterin Dihydrochloride Powder for Oral Solution, 100mg, a generic of BioMarin’s Kuvan (sapropterin dihydrochloride) Powder for Oral Solution, 100 mg, ... Read More
Dr. Reddy’s launches Sapropterin Dihydrochloride Tablets generic version in US
Indian pharma company Dr. Reddy’s Laboratories has launched a generic version of phenylalanine hydroxylase activator Sapropterin Dihydrochloride Tablets, for oral use, in the US market. ... Read More
Dr. Reddy’s appoints Marc Kikuchi as new head of generics business in North America
Dr. Reddy’s Laboratories has appointed Marc Kikuchi as CEO of its North America Generics unit. As part of the senior leadership team of Dr. Reddy’s ... Read More